The French Sunshine Act
The “Sunshine Act” was adopted in 2010 in the United States and in 2013 France enacted on its own version as part of the law to modernize the health system. To establish full transparency in the relationship between pharmaceutical companies and healthcare professionals, the “French Sunshine Act” imposes on companies an obligation to issue aggregate reports of all the benefits granted to healthcare professionals.
The new regulation provides that all agreements and benefits granted to health care professionals are to be made public. To comply with this new regulation companies must implement a well defied DMOS processes that combines data collection and expenditure breakdown with a reconciliation between hospitality and expenses incurred and a compliant validation process.
TOUS DROITS RESERVES